Multiple Myeloma: New Data On ZOLINZA (Vorinostat) In Combination With Bortezomib

Results from two Phase 1 studies of ZOLINZA® (vorinostat), Merck’s oral histone deacetylase (HDAC) inhibitor, administered in combination with bortezomib, showed early anti-tumor activity in patients with relapsed and/or refractory multiple myeloma, including those previously treated with and no longer responding to bortezomib.

More: continued here

Comments are closed.



Healthy Recipes 4 All - : Healthy Recipes 4 All
RX Pills Store - Buy Drugs: RX pills sotre
RX Discount Plus - Buy Drugs: Discount plus - A method that you get extra money even if you take discount products.
RX Pharmacy Online - Buy Drugs: RX Pharmacy Online
Drug any time - : Drug any time
Prescript aware - : Prescript aware
Rx Meds Online - Rx Meds Online: Medical Rx online
Rx store online - : Rx store online
Travellers pharmacy - : Pharmacy for people that travel
Latest News...